HY-135976-10mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
HY-135976-100mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
HY-135976-5mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
HY-135976-50mg
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4]
|
|
COVID-19-immunoregulation
|
|
HY-135976-1mL
|
MedChemexpress LLC
|
P2X3 antagonist 34 [CAS 2417288-67-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B1055-100mg
|
MedChemexpress LLC
|
Pentoxyverine (citrate) [CAS 23142-01-0]
|
|
COVID-19-immunoregulation
|
|
HY-B1055-500mg
|
MedChemexpress LLC
|
Pentoxyverine (citrate) [CAS 23142-01-0]
|
|
COVID-19-immunoregulation
|
|
HY-B1055-1mL
|
MedChemexpress LLC
|
Pentoxyverine (citrate) [CAS 23142-01-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-12887-10mg
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6]
|
|
COVID-19-immunoregulation
|
|
HY-12887-25mg
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6]
|
|
COVID-19-immunoregulation
|
|
HY-12887-5mg
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6]
|
|
COVID-19-immunoregulation
|
|
HY-12887-50mg
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6]
|
|
COVID-19-immunoregulation
|
|
HY-12887-1mL
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-15039-1mg
|
MedChemexpress LLC
|
SSR240612 [CAS 464930-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-15039-10mg
|
MedChemexpress LLC
|
SSR240612 [CAS 464930-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-15039-25mg
|
MedChemexpress LLC
|
SSR240612 [CAS 464930-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-15039-5mg
|
MedChemexpress LLC
|
SSR240612 [CAS 464930-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-13402A-10mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-13402A-100mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-13402A-25mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-13402A-5mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-13402A-50mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-13402-10mg
|
MedChemexpress LLC
|
Varespladib [CAS 172732-68-2]
|
|
COVID-19-immunoregulation
|
|
HY-13402-100mg
|
MedChemexpress LLC
|
Varespladib [CAS 172732-68-2]
|
|
COVID-19-immunoregulation
|
|
HY-13402-25mg
|
MedChemexpress LLC
|
Varespladib [CAS 172732-68-2]
|
|
COVID-19-immunoregulation
|
|